Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. is not a good value stock. Amylyx Pharmaceuticals, Inc. is not a good growth stock. Amylyx Pharmaceuticals, Inc. is not very popular among insiders. Amylyx Pharmaceuticals, Inc. is a mediocre stock to choose.

News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Hold" from Analysts

Ticker Report Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) have been assigned an average rating of "Hold" from the eight ratings firms that are presently covering the stock...\n more…

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of "Hold" from Analysts

Zolmax Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) have been given a consensus recommendation of "Hold" by the eight brokerages that are currently covering the company...\n more…

Allspring Global Investments Holdings LLC Acquires 13,509 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)

Ticker Report Allspring Global Investments Holdings LLC increased its holdings in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 88.4% in the 2nd quarter, according to the company in its...\n more…

Amylyx Pharmaceuticals: Management Ambitiously?Navigates Challenges

SeekingAlpha Amylyx Pharmaceuticals: Management Ambitiously?Navigates Challenges...\n more…

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Director Acquires $220,000.00 in Stock

Zolmax Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) Director George M. Milne, Jr. bought 100,000 shares of the company's stock in a transaction dated Tuesday, September 3rd. The stock was...\n more…

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Director George M. Milne, Jr. Acquires 100,000 Shares

Ticker Report Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) Director George M. Milne, Jr. purchased 100,000 shares of the firm's stock in a transaction on Tuesday, September 3rd. The shares were...\n more…